Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...
Multi-omics analyses reveal redundant functions of yeast mRNA decapping activators Scd6 and Edc3 in facilitating recruitment of helicase Dhh1 and accelerating degradation of transcripts required for ...
This study presents a valuable tool named TSvelo, a computational framework for RNA velocity inference that models transcriptional regulation and gene-specific splicing. The evidence supporting the ...
Q4 2025 Earnings Call Transcript November 25, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported ...
I will now hand the conference call over to Vince Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead, Vince. Thank you, Andrew. Good afternoon, and thank you for joining us ...
The "Human Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Human Vaccines was valued at US$46.9 Billion in 2024 and is ...
IQ Consortium experts explain how advanced chromatographic and analytical strategies are improving the bioanalysis, ...
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel ...
Tissue expansion, originally developed for super-resolution imaging, has become a foundation for expansion omics (ExO), a ...
6don MSN
Stick–slip nanopore approach streamlines protein analysis by using electrical 'fingerprints'
A technology developed in the laboratory of Prof. Amit Meller from the Technion—Israel Institute of Technology Faculty of ...
Our Shasta 3 and Shasta 4 phase three studies are designed to support an sNDA in this population, and while those studies are ...
Globally, metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease, affecting up to one in three people in the general population, with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results